A study of pembrolizumab and usual treatment for cervical cancer (The Papaya Study)
Cancer type:
Status:
Phase:
This study looked at whether pembrolizumab could improve treatment for cancer of the cervix.
More about this trial
- see if adding pembrolizumab to standard treatment keeps the cancer under control for longer
- learn more about the side effects
Summary of results
It was difficult to get enough women to join the trial. So the trial was never finished and there are no results available.
Recruitment start:
Recruitment end:
How to join a clinical trial
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Chief Investigator
Dr Susan Lalondrelle
Supported by
Biomedical Research Centre (BRC)
Merck, Sharpe & Dohme
Royal Marsden NHS Foundation Trust
If you have questions about the trial please contact our cancer information nurses
Freephone 0808 800 4040